{"nctId":"NCT00521586","briefTitle":"Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine","startDateStruct":{"date":"2007-09"},"conditions":["Influenza"],"count":1116,"armGroups":[{"label":"1","type":"OTHER","interventionNames":["Biological: 13 valent pneumococcal conjugate vaccine"]},{"label":"2","type":"OTHER","interventionNames":["Biological: 13 valent pneumococcal conjugate vaccine"]}],"interventions":[{"name":"13 valent pneumococcal conjugate vaccine","otherNames":["0.5 mL dose of TIV and 13vPnC at dose 1, 0.5 mL dose of of placebo at dose 2, and 0.5ml dose of 13vPnC at year 5 will be administered into left deltoid muscle"]},{"name":"13 valent pneumococcal conjugate vaccine","otherNames":["0.5 mL dose of TIV and of placebo at dose 1 and 0.5 mL dose of 13vPnC at dose 2 and year 5 will be administered into left deltoid muscle"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female aged 50 to 59 years\n* Determined by medical history, physical examination and clinical judgement to be eligible for the study\n* Able to complete electronic diary\n* Available for the 5 year 9 month duration of the study\n\nExclusion Criteria:\n\n* Previous vaccination with any licensed or experimental pneumococcal vaccine\n* Allergic to egg proteins and chicken proteins\n* History of Guillian-Barre syndrome\n* Vaccination with TIV within 6 months before study start\n* Vaccination with diphtheria-containing vaccine within 6 months of study start\n* Serious chronic disorders including immunodeficiency or metastatic malignancy\n* Known or suspected hypersensitivity to any vaccine or vaccine component","healthyVolunteers":true,"sex":"ALL","minimumAge":"50 Years","maximumAge":"59 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants Achieving at Least 4-fold Increase in Titer for Concomitant Trivalent Inactivated Influenza Vaccine (TIV) Antigens 1 Month After Dose 1","description":"Percentage of participants achieving at least 4-fold increase in titer for concomitant Trivalent Inactivated Influenza Vaccine (TIV) were measured by standard Hemagglutination Inhibition Assay (HAI) for the A/H1, A/H3, and B vaccine strains.Exact, unconditional, 2-sided, 95% confidence intervals (CI) on the difference in proportions (13vPnC+TIV - Placebo+TIV) was calculated. N(number of participants analyzed)=participants with a determinate antibody titer to the given concomitant vaccine antigen. n=participants who met the prespecified level for the given antigen.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"84.0","spread":null},{"groupId":"OG001","value":"81.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.1","spread":null},{"groupId":"OG001","value":"69.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60.6","spread":null},{"groupId":"OG001","value":"60.3","spread":null}]}]}]},{"type":"PRIMARY","title":"Geometric Mean Concentration (GMC) for Serotype-specific Pneumococcal Immunoglobulin G (IgG) Antibody 1 Month After 13vPnC Dose","description":"Antibody GMC for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) for adult participants are presented. GMC (13vPnC) and corresponding 2-sided 95 percent (%) CIs were evaluated. Geometric means were calculated using all participants with available data for 1 month after 13vPnC Dose at year 0 blood draw. CI for GMC are back transformations of a CI based on the Student t distribution for the mean logarithm of the concentrations.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.05","spread":null},{"groupId":"OG001","value":"5.45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.15","spread":null},{"groupId":"OG001","value":"1.46","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.35","spread":null},{"groupId":"OG001","value":"3.41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.03","spread":null},{"groupId":"OG001","value":"7.18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.78","spread":null},{"groupId":"OG001","value":"6.70","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.58","spread":null},{"groupId":"OG001","value":"10.09","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.14","spread":null},{"groupId":"OG001","value":"10.57","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.96","spread":null},{"groupId":"OG001","value":"6.97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.77","spread":null},{"groupId":"OG001","value":"14.05","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.65","spread":null},{"groupId":"OG001","value":"13.49","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.80","spread":null},{"groupId":"OG001","value":"18.84","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.13","spread":null},{"groupId":"OG001","value":"7.13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.17","spread":null},{"groupId":"OG001","value":"8.54","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMT) 1 Month After 13vPnC (Year 5)","description":"Serotype-specific OPA GMTs for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of participants using a microcolony OPA (mcOPA) assay. GMTs (13vPnC) and corresponding 2-sided 95% CIs were evaluated. Geometric means were calculated using all participants with available data for 1 Month After 13vPnC (Year 5) blood draws. CI for GMTs were back transformations of a CI based on the Student t distribution for the mean logarithm of the titers.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"178","spread":null},{"groupId":"OG001","value":"168","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null},{"groupId":"OG001","value":"66","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1618","spread":null},{"groupId":"OG001","value":"1491","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"267","spread":null},{"groupId":"OG001","value":"312","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4266","spread":null},{"groupId":"OG001","value":"3994","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3583","spread":null},{"groupId":"OG001","value":"3567","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1636","spread":null},{"groupId":"OG001","value":"1803","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1818","spread":null},{"groupId":"OG001","value":"1551","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1110","spread":null},{"groupId":"OG001","value":"1107","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1800","spread":null},{"groupId":"OG001","value":"1738","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"913","spread":null},{"groupId":"OG001","value":"890","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1202","spread":null},{"groupId":"OG001","value":"1140","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1837","spread":null},{"groupId":"OG001","value":"1820","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) Before 13vPnC (Year 5) and 1 Month After 13vPnC Re-vaccinated Dose (Year 5)","description":"Serotype-specific OPA GMTs for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of participants using a microcolony OPA (mcOPA) assay. GMTs (13vPnC) and corresponding 2-sided 95% CIs were evaluated. Geometric means were calculated using all participants with available data for before 13vPnC (Year 5) and 1 month after 13vPnC re-vaccinated dose (Year 5) blood draws. CI for GMTs were back transformations of a CI based on the Student t distribution for the mean logarithm of the titers. Participants with immunogenicity data at both Year 5 endpoints.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"173","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1553","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"290","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"173","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4072","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"209","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3504","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"122","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1697","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1669","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"289","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1096","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"120","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1748","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"113","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"900","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1146","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1819","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Fold-Rises (GMFRs) 1 Month After 13vPnC Re-vaccinated Dose (Year 5) Relative to Before 13vPnC (Year 5)","description":"GMFR for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined from before 13vPnC (Year 5) to 1 month after 13vPnC re-vaccinated dose (Year 5) and were summarized geometric means and 2-sided 95% CIs, which were computed using the logarithmically transformed assay results. CI for GMFRs were back transformations of a CI based on the Student t distribution for the mean logarithm of the mean fold rises. GMFRs were calculated using all participants with available data from both before 13vPnC (Year 5) and 1 month after 13vPnC re-vaccinated dose (Year 5) blood draws. n=participants with valid and determinate assay results for the specified serotype from both before 13vPnC (Year 5) and 1 month after 13vPnC re-vaccinated dose (Year 5) blood draws.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) 1 Month After 13vPnC (Year 0) and 1 Month After 13vPnC Re-vaccinated Dose (Year 5)","description":"Serotype-specific OPA GMTs for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of participants using a microcolony OPA (mcOPA) assay. GMTs (13vPnC) and corresponding 2-sided 95% CIs were evaluated. Geometric means were calculated using all participants with available data for 1 month after 13vPnC (Year 0),1 month after 13vPnC re-vaccinated dose (Year 5) blood draws. CI for GMTs were back transformations of a CI based on the Student t distribution for the mean logarithm of the titers. Participants in this population must have immunogenicity data at both the Year 0 and Year 5 time points.n=participants with valid and determinate assay results for the specified serotype for both 1 month after 13vPnC (Year 0),1 month after 13vPnC re-vaccinated dose (Year 5) blood draws.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"217","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"183","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1905","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1589","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"129","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"300","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2779","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4196","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3089","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3541","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2196","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1768","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1343","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1768","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1169","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1135","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1728","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1772","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"879","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"858","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"472","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1139","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"494","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1955","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-Specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Fold Rises (GMFRs) 1 Month After 13vPnC Re-vaccinated Dose (Year 5) Relative to 1 Month After 13vPnC (Year 0)","description":"GMFR for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined from 1 month after 13vPnC (Year 0),1 month after 13vPnC re-vaccinated dose (Year 5) and were summarized geometric means and 2-sided 95% CIs, which were computed using the logarithmically transformed assay results. CI for GMFRs were back transformations of a CI based on the Student t distribution for the mean logarithm of the mean fold rises. GMFRs were calculated using all participants with available data from both 1 month after 13vPnC (Year 0),1 month after 13vPnC re-vaccinated dose (Year 5) blood draws.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) Before 13vPnC (Year 0) and 1 Month After 13vPnC Re-vaccinated Dose (Year 5)","description":"Serotype-specific OPA GMTs for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of participants using a microcolony OPA (mcOPA) assay. GMTs (13vPnC) and corresponding 2-sided 95% CIs were evaluated. Geometric means were calculated using all participants with available data for before 13vPnC (Year 0) and 1 month after 13vPnC re-vaccinated dose (Year 5) blood draws. CI for GMTs were back transformations of a CI based on the Student t distribution for the mean logarithm of the titers. Participants in this population must have immunogenicity data at both the Year 0 and Year 5 time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"171","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1558","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"284","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4072","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3341","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1818","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1725","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1164","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1824","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"849","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1106","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1851","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-Specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Fold Rises (GMFRs) 1 Month After 13vPnC Re-vaccinated Dose (Year 5) Relative to Before 13vPnC (Year 0)","description":"GMFR for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined from before13vPnC (Year 0) to 1 month after 13vPnC re-vaccinated dose (Year 5) and were summarized geometric means and 2-sided 95% CIs, which were computed using the logarithmically transformed assay results. CI for GMFRs were back transformations of a CI based on the Student t distribution for the mean logarithm of the mean fold rises. GMFRs were calculated using all participants with available data from both before 13vPnC (Year 0) and 1 month after 13vPnC re-vaccinated dose (Year 5) blood draws.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"224.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"63.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"188.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"80.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"216.5","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-Specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMT) Before and 1 Month After 13vPnC (Year 0), 1, 2, 3, 4 Years After Initial Vaccination (Year 0); Before and 1 Month After 13vPnC (Year 5)","description":"Serotype-specific OPA GMTs for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of participants using a microcolony OPA (mcOPA) assay. GMT (13vPnC) and corresponding 2-sided 95% CIs were evaluated. Geometric means were calculated using all participants with available data before, 1 month after 13vPnC (Year 0), at Years 1, 2, 3 and 4 after initial vaccination (Year 0), before, 1 month after 13vPnC (Year 5) blood draws. CI for GMT were back transformations of a CI based on the Student t distribution for the mean logarithm of the titers. n=participants with valid and determinate assay results for the specified serotype at before, 1 month after 13vPnC (Year 0), at Years 1, 2, 3 and 4 after initial vaccination (Year 0), before, 1 month after 13vPnC (Year 5) blood draws.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"200","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"203","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1896","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"442","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"181","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"137","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1574","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"145","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"273","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2158","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"748","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"405","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"282","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"203","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"166","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3777","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2950","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"765","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"505","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"373","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"326","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"229","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3804","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2265","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"515","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"279","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"253","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"175","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"155","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1932","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1202","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"276","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"66","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"86","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1572","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1436","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"541","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"446","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"416","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"341","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"335","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1238","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1189","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"301","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"170","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"115","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"102","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1580","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"727","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"193","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"874","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"448","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"85","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1112","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"396","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"48","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1642","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Fold Rises (GMFRs) 1 Month After 13vPnC (Year 0),1, 2, 3, 4 Years After Initial Vaccination (Year 0); Before and 1 Month After 13vPnC (Year 5) Relative to Before 13vPnC (Year 0)","description":"GMFR for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined from before to 1 month after 13vPnC (Year 0), at years 1, 2, 3 and 4 after initial vaccination (Year 0), before, 1 month after 13vPnC (Year 5) and were summarized geometric means and 2-sided 95% CIs, which were computed using the logarithmically transformed assay results. CI for GMFRs were back transformations of a CI based on the Student t distribution for the mean logarithm of the mean fold rises. GMFRs were calculated using all participants with available data from both the baseline and the various time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"98.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"126.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"219.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"168.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"163.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"58.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"82.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"81.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"194.0","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-Specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentration (GMCs) 1 Month After 13vPnC (Year 5)","description":"Antibody GMC for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) for adult participants are presented. GMC (13vPnC) and corresponding 2-sided 95 percent (%) CIs were evaluated. Geometric means were calculated using all participants with available data for 1 month after 13vPnC Dose 1 blood draw. CI for GMC are back transformations of a CI based on the Student t distribution for the mean logarithm of the concentrations.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.92","spread":null},{"groupId":"OG001","value":"5.83","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.69","spread":null},{"groupId":"OG001","value":"0.72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.90","spread":null},{"groupId":"OG001","value":"4.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.49","spread":null},{"groupId":"OG001","value":"8.02","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.59","spread":null},{"groupId":"OG001","value":"13.45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.18","spread":null},{"groupId":"OG001","value":"21.76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.48","spread":null},{"groupId":"OG001","value":"8.70","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.91","spread":null},{"groupId":"OG001","value":"6.35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.57","spread":null},{"groupId":"OG001","value":"16.39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.77","spread":null},{"groupId":"OG001","value":"8.46","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.77","spread":null},{"groupId":"OG001","value":"17.97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.83","spread":null},{"groupId":"OG001","value":"18.18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.15","spread":null},{"groupId":"OG001","value":"20.25","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentration (GMCs) Before 13vPnC (Year 5) and 1 Month After 13vPnC Re-vaccinated Dose (Year 5)","description":"Antibody GMC for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) for adult participants are presented. GMC (13vPnC) and corresponding 2-sided 95% CIs were evaluated. Geometric means were calculated using all participants with available data before 13vPnC (Year 5) and 1 month after 13vPnC re-vaccinated dose (Year 5) blood draw. CI for GMC are back transformations of a CI based on the Student t distribution for the mean logarithm of the concentrations. Participants in this population must have immunogenicity data at both Year 5 time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.27","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.87","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.71","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.83","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.04","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.47","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.73","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.23","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Fold Rises (GMFRs) 1 Month After 13vPnC Re-vaccinated Dose (Year 5) Relative to Before 13vPnC (Year 5)","description":"GMFR for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined from before 13vPnC (Year 5) to 1 month after 13vPnC re-vaccinated dose (Year 5) and were summarized geometric means and 2-sided 95% CIs, which were computed using the logarithmically transformed assay results. CI for GMFRs were back transformations of a CI based on the Student t distribution for the mean logarithm of the mean fold rises. GMFRs were calculated using all participants with available data from both before 13vPnC (Year 5) and 1 month after 13vPnC re-vaccinated dose (Year 5) blood draws.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.46","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.69","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentration (GMCs) 1 Month After 13vPnC (Year 0) and 1 Month After 13vPnC Re-vaccinated Dose (Year 5)","description":"Antibody GMC for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) for adult participants are presented. GMC (13vPnC) and corresponding 2-sided 95% CIs were evaluated. Geometric means were calculated using all participants with available data 1 month after 13vPnC (Year 0),1 month after 13vPnC re-vaccinated dose (Year 5) blood draw. CI for GMC are back transformations of a CI based on the Student t distribution for the mean logarithm of the concentrations. Participants in this population must have immunogenicity data at both the Year 0 and Year 5 time points","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.87","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.70","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.40","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.83","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.07","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.98","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.04","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.48","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.03","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.17","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Fold Rises (GMFRs) 1 Month After 13vPnC Re-vaccinated Dose (Year 5) Relative to 1 Month After 13vPnC (Year 0)","description":"GMFR for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined from 1 month after 13vPnC (Year 0),1 month after 13vPnC re-vaccinated dose (Year 5) and were summarized geometric means and 2-sided 95% CIs, which were computed using the logarithmically transformed assay results. CI for GMFRs were back transformations of a CI based on the Student t distribution for the mean logarithm of the mean fold rises. GMFRs were calculated using all participants with available data from both 1 month after 13vPnC (Year 0),1 month after 13vPnC re-vaccinated dose (Year 5) blood draws.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.23","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.91","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.04","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.71","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.06","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.78","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.51","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-Specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentration (GMCs) Before 13vPnC (Year 0) and 1 Month After 13vPnC Re-vaccinated Dose (Year 5)","description":"Antibody GMC for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) for adult participants are presented. GMC (13vPnC) and corresponding 2-sided 95% CIs were evaluated. Geometric means were calculated using all participants with available data before 13vPnC (Year 0) and 1 month after 13vPnC re-vaccinated dose (Year 5) blood draw. CI for GMC are back transformations of a CI based on the Student t distribution for the mean logarithm of the concentrations. Participants in this population must have immunogenicity data at both the Year 0 and Year 5 time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.86","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.47","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.22","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.79","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.09","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.70","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.87","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.07","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.95","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.98","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.92","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.68","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.53","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Fold Rises (GMFRs) 1 Month After 13vPnC Re-vaccinated Dose (Year 5) Relative to Before 13vPnC (Year 0)","description":"GMFR for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined from Before 13vPnC (Year 0) to 1 month after 13vPnC re-vaccinated dose (Year 5) and were summarized geometric means and 2-sided 95% CIs, which were computed using the logarithmically transformed assay results. CI for GMFRs were back transformations of a CI based on the Student t distribution for the mean logarithm of the mean fold rises. GMFRs were calculated using all participants with available data from both before 13vPnC (Year 0),1 month after 13vPnC re-vaccinated dose (Year 5) blood draws.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.57","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.96","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.96","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.68","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.04","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.95","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.18","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Geometric Mean Concentration (GMC) for Serotype-specific Pneumococcal Immunoglobulin G (IgG) Antibody Before and 1 Month After 13vPnC (Year 0), 1, 2, 3, 4 Years After Initial Vaccination (Year 0); Before and 1 Month After 13vPnC (Year 5)","description":"Participants received either 0.5 mL dose of 13vPnC intramuscular injection into the deltoid muscle of the left arm along with 0.5-mL TIV intramuscular injection into the deltoid muscle of the right arm at Year 0 on Day 1(Dose1, 13vPnC+TIV), or placebo matched to 13vPnC intramuscular injection into the deltoid muscle of the left arm along with 0.5-mL TIV intramuscular injection into the deltoid muscle of the right arm at Year 0 on Day 1(Dose 1, placebo+TIV). Placebo matched to 13vPnC was administered 1 month after(Dose 2, placebo), or 13vPnC was administered 1 month after (Dose 2, 13vPnC).Participants were further followed-up for 1 month,then attended a 6-month follow-up visit for safety.Participants were then followed-up yearly for 4 years.Participants then received 0.5 mL dose of 13vPnC intramuscular injection into the deltoid muscle of the left arm 5 years after initial vaccination.Participants were further followed-up for 1 month, then attended a 6-month follow-up visit for safety.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.53","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.96","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.08","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.30","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.30","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.66","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.98","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.40","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.40","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.31","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.96","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.53","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.61","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.05","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.84","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.09","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.48","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.71","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.71","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.31","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.30","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.85","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.94","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.57","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.95","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.47","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.87","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.06","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.95","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Fold Rises (GMFRs) 1 Month After 13vPnC (Year 0),1, 2, 3, 4 Years After Initial Vaccination (Year 0); Before and 1 Month After 13vPnC (Year 5) Relative to Before 13vPnC (Year 0)","description":"GMFR for the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined from before to 1 month after 13vPnC (Year 0), at years 1, 2, 3 and 4 after initial vaccination (Year 0), before, 1 month after 13vPnC (Year 5) and were summarized geometric means and 2-sided 95% CIs, which were computed using the logarithmically transformed assay results. CI for GMFRs were back transformations of a CI based on the Student t distribution for the mean logarithm of the mean fold rises. GMFRs were calculated using all participants with available data from both the baseline and the various time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.73","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.01","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.79","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.89","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.81","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.00","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.05","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.86","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.84","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.66","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.96","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.91","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.92","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.03","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.87","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.81","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.47","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.00","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.54","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.84","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.68","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.94","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.86","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.73","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.06","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.87","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.00","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.02","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.01","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.57","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.09","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.48","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.52","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After Dose 1 (Year 0)","description":"Specific local reactions were prompted for each day,and reported using an electronic diary.Redness and Swelling were scaled as Any(redness present or swelling present);Mild(2.5 to 5.0 centimeters \\[cm\\]);Moderate(5.1 to 10.0 cm);Severe (\\>10 cm). Pain at injection site was scaled as: Any (pain present); Mild (awareness of sign or symptom, but easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating, with inability to do usual activity). Limitation of arm movement was scaled as Any(no limitation of arm movement);Mild(some limitation of arm movement);Moderate (unable to move arm above head but able to move arm above shoulder);Severe (unable to move arm above shoulder). Local reactions were measured only on the participant's arm vaccinated with either 13vPnC or placebo and were not collected at the TIV injection site.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.3","spread":null},{"groupId":"OG001","value":"3.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.7","spread":null},{"groupId":"OG001","value":"2.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":null},{"groupId":"OG001","value":"0.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.4","spread":null},{"groupId":"OG001","value":"3.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.0","spread":null},{"groupId":"OG001","value":"3.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.7","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"86.8","spread":null},{"groupId":"OG001","value":"37.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"82.8","spread":null},{"groupId":"OG001","value":"35.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.2","spread":null},{"groupId":"OG001","value":"4.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.1","spread":null},{"groupId":"OG001","value":"0.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.6","spread":null},{"groupId":"OG001","value":"8.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.6","spread":null},{"groupId":"OG001","value":"8.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.2","spread":null},{"groupId":"OG001","value":"1.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":null},{"groupId":"OG001","value":"0.8","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After Dose 2 (Year 0)","description":"Specific local reactions were prompted for each day,and reported using an electronic diary.Redness and Swelling were scaled as Any(redness present or swelling present);Mild(2.5 to 5.0 centimeters \\[cm\\]);Moderate(5.1 to 10.0 cm);Severe (\\>10 cm). Pain at injection site was scaled as: Any (pain present); Mild (awareness of sign or symptom, but easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating, with inability to do usual activity). Limitation of arm movement was scaled as Any(no limitation of arm movement);Mild(some limitation of arm movement);Moderate (unable to move arm above head but able to move arm above shoulder);Severe (unable to move arm above shoulder). Local reactions were measured only on the participant's arm vaccinated with either 13vPnC or placebo and were not collected at the TIV injection site.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":null},{"groupId":"OG001","value":"12.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":null},{"groupId":"OG001","value":"10.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"5.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"1.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":null},{"groupId":"OG001","value":"14.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":null},{"groupId":"OG001","value":"12.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":null},{"groupId":"OG001","value":"6.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.0","spread":null},{"groupId":"OG001","value":"84.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.7","spread":null},{"groupId":"OG001","value":"82.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":null},{"groupId":"OG001","value":"41.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"4.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.3","spread":null},{"groupId":"OG001","value":"42.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.3","spread":null},{"groupId":"OG001","value":"41.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":null},{"groupId":"OG001","value":"5.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"2.9","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After 13vPnC (Year 5)","description":"Specific local reactions were prompted for each day,and reported using an electronic diary.Redness and Swelling were scaled as Any(redness present or swelling present);Mild(2.5 to 5.0 centimeters \\[cm\\]);Moderate(5.1 to 10.0 cm);Severe (\\>10 cm). Pain at injection site was scaled as: Any (pain present); Mild (awareness of sign or symptom, but easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating, with inability to do usual activity). Limitation of arm movement was scaled as Any(no limitation of arm movement);Mild(some limitation of arm movement);Moderate (unable to move arm above head but able to move arm above shoulder);Severe (unable to move arm above shoulder).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.7","spread":null},{"groupId":"OG001","value":"20.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.0","spread":null},{"groupId":"OG001","value":"17.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.1","spread":null},{"groupId":"OG001","value":"12.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":null},{"groupId":"OG001","value":"0.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.8","spread":null},{"groupId":"OG001","value":"18.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.5","spread":null},{"groupId":"OG001","value":"15.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.1","spread":null},{"groupId":"OG001","value":"9.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"1.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"79.2","spread":null},{"groupId":"OG001","value":"79.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.4","spread":null},{"groupId":"OG001","value":"74.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.7","spread":null},{"groupId":"OG001","value":"34.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.4","spread":null},{"groupId":"OG001","value":"3.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.2","spread":null},{"groupId":"OG001","value":"26.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.3","spread":null},{"groupId":"OG001","value":"22.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.9","spread":null},{"groupId":"OG001","value":"3.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":null},{"groupId":"OG001","value":"3.4","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After Dose 1 (Year 0)","description":"Percentage of participants who experienced specific systemic events (mild: 38.0 to 38.4 degrees Celsius \\[C\\], moderate: 38.5 to 38.9 degrees C, severe: 39.0 to 40.0 degrees C and potentially life threatening greater than \\[\\>\\] 40.0 degrees C), chills, fatigue, headache, vomiting, decreased appetite, rash, new generalized muscle pain, aggravated generalized muscle pain, new generalized joint pain, and aggravated generalized joint pain prompted for each day were reported using an electronic diary.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":null},{"groupId":"OG001","value":"1.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"58.1","spread":null},{"groupId":"OG001","value":"52.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65.9","spread":null},{"groupId":"OG001","value":"56.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.4","spread":null},{"groupId":"OG001","value":"21.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.6","spread":null},{"groupId":"OG001","value":"4.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.3","spread":null},{"groupId":"OG001","value":"3.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.2","spread":null},{"groupId":"OG001","value":"22.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65.5","spread":null},{"groupId":"OG001","value":"37.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.7","spread":null},{"groupId":"OG001","value":"24.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.0","spread":null},{"groupId":"OG001","value":"24.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.2","spread":null},{"groupId":"OG001","value":"18.0","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After Dose 2 (Year 0)","description":"Percentage of participants who experienced specific systemic events (absent: 38.0 degrees Celsius \\[C\\], mild: 38.0 to 38.4 degrees C, moderate: 38.5 to 38.9 degrees C, severe: 39.0 to 40.0 degrees C and potentially life threatening \\> 40.0 degrees C), chills, fatigue, headache, vomiting, decreased appetite, rash, new generalized muscle pain, aggravated generalized muscle pain, new generalized joint pain, and aggravated generalized joint pain prompted for each day were reported using an electronic diary.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":null},{"groupId":"OG001","value":"1.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":null},{"groupId":"OG001","value":"0.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":null},{"groupId":"OG001","value":"0.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.7","spread":null},{"groupId":"OG001","value":"51.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"48.2","spread":null},{"groupId":"OG001","value":"50.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.5","spread":null},{"groupId":"OG001","value":"24.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.1","spread":null},{"groupId":"OG001","value":"9.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.9","spread":null},{"groupId":"OG001","value":"6.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.4","spread":null},{"groupId":"OG001","value":"25.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.5","spread":null},{"groupId":"OG001","value":"59.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.7","spread":null},{"groupId":"OG001","value":"36.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.5","spread":null},{"groupId":"OG001","value":"27.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.5","spread":null},{"groupId":"OG001","value":"23.8","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After 13vPnC (Year 5)","description":"Percentage of participants who experienced specific systemic events (Fever: \\>= 38.0 degrees Celsius \\[C\\], mild: 38.0 to 38.4 degrees C, moderate: 38.5 to 38.9 degrees C, severe: 39.0 to 40.0 degrees C and potentially life threatening \\> 40.0 degrees C), chills, fatigue, headache, vomiting, decreased appetite, rash, new generalized muscle pain, aggravated generalized muscle pain, new generalized joint pain, and aggravated generalized joint pain prompted for each day were reported using an electronic diary.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":null},{"groupId":"OG001","value":"5.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null},{"groupId":"OG001","value":"2.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":null},{"groupId":"OG001","value":"2.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null},{"groupId":"OG001","value":"1.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.7","spread":null},{"groupId":"OG001","value":"45.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.9","spread":null},{"groupId":"OG001","value":"51.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.1","spread":null},{"groupId":"OG001","value":"22.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.7","spread":null},{"groupId":"OG001","value":"13.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":null},{"groupId":"OG001","value":"7.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.4","spread":null},{"groupId":"OG001","value":"22.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47.7","spread":null},{"groupId":"OG001","value":"51.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.9","spread":null},{"groupId":"OG001","value":"27.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.2","spread":null},{"groupId":"OG001","value":"21.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.4","spread":null},{"groupId":"OG001","value":"18.2","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Acute Pain Within 30 Minutes After Dose 1 (Year 0)","description":"Acute pain was not prompted in the electronic diary however were recorded in a specific page of the case report form (CRF). Acute pain at injection site pain occurred within 30 minutes of vaccination and was scaled as: Any (pain present); Mild (easily tolerated); Moderate (discomfort interfering the usual activity); Severe (Incapacitating with inability to do usual activity). Acute pain was measured only on the participant's arm vaccinated with either 13vPnC or placebo and were not collected at the TIV injection site.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":null},{"groupId":"OG001","value":"6.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":null},{"groupId":"OG001","value":"6.3","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Acute Pain Within 30 Minutes After Dose 2 (Year 0)","description":"Acute pain was not prompted in the electronic diary however were recorded in a specific page of the case report form (CRF). Acute pain at injection site pain occurred within 30 minutes of vaccination and was scaled as: Any (pain present); Mild (easily tolerated); Moderate (discomfort interfering the usual activity); Severe (Incapacitating with inability to do usual activity). Acute pain was measured only on the participant's arm vaccinated with either 13vPnC or placebo and were not collected at the TIV injection site.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":null},{"groupId":"OG001","value":"6.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":null},{"groupId":"OG001","value":"6.4","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Acute Pain Within 30 Minutes After 13vPnC (Year 5)","description":"Acute pain was not prompted in the electronic diary however were recorded in a specific page of the case report form (CRF). Acute pain at injection site pain occurred within 30 minutes of vaccination and was scaled as: Any (pain present); Mild (easily tolerated); Moderate (discomfort interfering the usual activity); Severe (Incapacitating with inability to do usual activity).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":null},{"groupId":"OG001","value":"4.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.3","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.1","spread":null},{"groupId":"OG001","value":"4.4","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants With Serious Adverse Events (SAEs) or Non-serious Adverse Events (Non-SAEs)","description":"AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. Non-serious AEs are AEs excluding SAEs. In Years 1-4, only deaths and withdrawals due to AEs or SAEs were to be recorded in the case report form.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":null},{"groupId":"OG001","value":"0.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":null},{"groupId":"OG001","value":"1.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":null},{"groupId":"OG001","value":"1.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":null},{"groupId":"OG001","value":"0.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":null},{"groupId":"OG001","value":"0.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":null},{"groupId":"OG001","value":"0.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":null},{"groupId":"OG001","value":"0.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.2","spread":null},{"groupId":"OG001","value":"13.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.3","spread":null},{"groupId":"OG001","value":"10.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.7","spread":null},{"groupId":"OG001","value":"3.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.3","spread":null},{"groupId":"OG001","value":"68.3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":551},"commonTop":["Any systemic event","Any local reaction","Pain: Any","Pain: Mild","Headache: any"]}}}